Numerous advancements have impacted clinical development over the past year, including new modalities, breakthrough technologies, digital transformation, and novel clinical trial designs. We continue to see immense growth potential in the biotech industry with never-before-seen CRISPR technology and robust cell and gene therapies progressing through late-stage clinical trials; however, we also see challenges with increased market competition and lack of funding for more complex treatment
关注微信
